US Patent 8945534 Controlled activation of the reuterin-production machinery of
Patent 8945534 was granted and assigned to BioGaia on February, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8945534 Controlled activation of the reuterin-production machinery of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.